Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies

References

• Lenmark A. Glutamic acid decarboxylase—gene to antigen to disease. J Intern Med 1996; 240: 259–277
   PubMed Web of Science ®Google Scholar
• Hagopian WA, Karlsen AE, Gottsater A, Landin-Olsson M, Grubin CE, Sundkvist G, Petersen JS, Boel E, Dyrberg T, Lernmark A. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD 65) shows that 64 K autoantibody positivity at onset predicts diabetes type. J Clin Invest 1993; 91: 368
   PubMed Web of Science ®Google Scholar
• De Aizpurua HJ, Wilson YM, Harrison LC. Glutamic acid decarboxylase antibodies in preclinical insulin-dependent diabetes. Proc Natl Acad Sci USA 1992; 89: 9841–9845
   PubMed Web of Science ®Google Scholar
• Luhder F, Schlosser M, Mauch L, Haubruck H, Rjasanowski I, Michaelis D, Kohnert KD, Ziegler M. Autoantibodies against GAD65 rather than GAD67 precede the onset of type 1 diabetes. Autoimmunity 1994; 19: 71–80
   PubMed Web of Science ®Google Scholar
• Solimena M, Folli F, Denis-Donini S, Comi GC, Pozza G, De Camilli P, Vicari AM. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and Type I diabetes mellitus. N Engl J Med 1988; 318: 1012–1020
   PubMed Web of Science ®Google Scholar
• Vaconcelos OM, Dalakas MC. Stiff-person syndrome. Curr Tret Options Neurol 2003; 5: 79–90
   PubMedGoogle Scholar
• Giometto B, Miotto D, Faresin F, Argentiero V, Scaravilli T, Tavolato B. Anti-gabaergic neuron autoantibodies in a patient with stiff-man syndrome and ataxia. J Neurol Sci 1996; 143: 57–59
   PubMed Web of Science ®Google Scholar
• Honnorat J, Trouillas P, Thivolet C, Aguera M, Belin MF. Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements. Arch Neurol 1995; 52: 462–468
   PubMedGoogle Scholar
• Casamitjana R, Zarranz JJ, Tolosa E, Graus F. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology 1997; 49: 1026–1030
   PubMed Web of Science ®Google Scholar
• Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: Clinical and immunological study of 14 patients. Arch Neurol 2001; 58: 225–230
   PubMedGoogle Scholar
• Giometto B, Nicolao P, Macucci M, Tavolato B, Foxon R, Bottazzo GF. Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. Lancet 1998; 352: 457
   PubMed Web of Science ®Google Scholar
• Peltola J, Kulmala P, Isojärvi J, Saiz A, Latvala K, Palmio J, et al. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 2000; 55: 46–56
   PubMed Web of Science ®Google Scholar
• Nemni R, Braghi S, Natali-Sora MG, Lampasona V, Bonifacio E, Comi G, Canal N. Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy. Ann Neurol 1994; 36: 665–667
   PubMed Web of Science ®Google Scholar
• Vianello M, Morello F, Scaravilli T, Tavolato B, Giometto B. Tremour of the mouth floor and anti-glutamic acid decarboxylase autoantibodies. Eur J Neurol 2003; 10: 513–514
   PubMed Web of Science ®Google Scholar
• Giometto B, Scaravilli T, Nicolao P, An SF, Groves M, Tavolato B, Beckett AA, Scaravilli F. Detection of paraneoplastic anti-neuronal autoantibodies on paraffin-embedded tissues. Acta Neuropathol 1996; 92: 435–440
   PubMed Web of Science ®Google Scholar
• Schmidli RS, Colman PG, Bonifacio E, Bottazzo GF, Harrison LC. High level of concordance between assays for glutamic acid decarboxylase antibodies. The first international glutamic acid decarboxylase antibody workshop. Diabetes 1994; 43: 1005–1009
   PubMed Web of Science ®Google Scholar
• Vianello M, Keir G, Giometto B, Betterle C, Tavolato B, Thompson EJ. Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase autoantibodies. Eur J Neurol 2005; 12: 294–299
   PubMed Web of Science ®Google Scholar
• Dinkel K, Meinck H-M, Jury KM, Karges W, Richter W. Inhibition of γ-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome. Ann Neurol 1998; 44: 194–201
   PubMed Web of Science ®Google Scholar
• Ishida K, Mitoma H, Song SY, Uchihara T, Inaba A, Eguchi S, Kobayashi T, Mizusawa H. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol 1999; 46: 263–267
   PubMed Web of Science ®Google Scholar
• Mitoma H, Song SY, Ishida K, Yamakuni T, Kobayashi T, Mizusawa H. Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase. J Neurol Sci 2000; 175: 40–44
   PubMed Web of Science ®Google Scholar
• Takenoshita H, Shizuka-Ikeda M, Mitoma H, Song S, Harigaya Y, Igeta Y, et al. Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia. JNNP 2001; 70: 386–389
   PubMed Web of Science ®Google Scholar
• Vianello M, Giometto B, Vassanelli S, Canato M, Betterle C, Mucignat C. Peculiar labelling of cultured hippocampal neurons by different sera harbouring anti-glutamic acid decarboxylase autoantibodies (GAD-Ab). Exp Neurol 2006; 202: 514–518
   PubMed Web of Science ®Google Scholar
• Franaszczuk PJ, Bergey GK, Kudela P. Detection of spontaneous postsynaptic potentials. Comput Biomed Res 1995; 28(5)354–370
   PubMedGoogle Scholar
• Moré JJ, Sorensen DC. Computing a trust region step. SIAM J Sci Stat Comput 1983; 3: 553–572
   Web of Science ®Google Scholar
• Destexhe A, Mainen ZF, Sejnowski TJ. Synthesis of models for excitable membranes, synaptic transmission and neuromodulation using a common kinetic formalism. J Comput Neurosci 1994; 1(3)195–230
   PubMedGoogle Scholar
• Dayan P, Abbott LF. Theoretical neuroscience: Computational and mathematical modelling of neural systems. MIT Press, Cambridge, MA 2001
   Google Scholar
• Dupuy ST, Houser CR. Prominent expression of two forms of glutamate decarboxylase in the embryonic and early postnatal rat hippocampal formation. J Neurol Sci 1996; 16: 6919–6932
   Google Scholar
• Kato-Negishi M, Muramoto K, Kawahara M, Kuroda Y, Ichikawa M. Developmental changes of GABAergic synapses formed between primary cultured cortical neurons. Dev Brain Res 2004; 152: 99–108
   PubMedGoogle Scholar
• Alarcon-Segovia D, Ruid-Arguelles A, Llorente L. Broken dogma: Penetration of autoantibodies into living cells. Immunol Today 1996; 17: 163–164
   PubMedGoogle Scholar
• Madaio MP, Fabbi M, Tiso M. Spontaneously produced anti-DNA/DNase I autoantibodies modulate nuclear apoptosis in living cells. Eur J Immunol 1996; 26: 3035–3041
   PubMed Web of Science ®Google Scholar
• Koerner C, Wieland B, Richter W, Meinck HM. Stiff-person syndromes. Motor cortex hyperexcitability correlates with anti-GAD autoimmunity. Neurology 2004; 62: 1357–1362
   PubMed Web of Science ®Google Scholar
• Kash SF, Johnson RS, Tecott LH, Noebels JL, Mayfield RD, Hanahan D, Baekkeskov S. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 1997; 94: 14060–14065
   PubMed Web of Science ®Google Scholar
• During MJ, Symes CW, Lawlor PA, Lin J, Dunning J, Fitzsimons HL, et al. An oral vaccine against NMDAR1 with efficacy in experimental stroke and epilepsy. Science 2000; 287: 1453–1459
   PubMed Web of Science ®Google Scholar